Tuesday, 09 December 2025

Safety concerns raised for neuroblastoma candidate drug

Added: 09.11.2021 17:03 | 200 views | 0 comments

Source: www.expressandstar.com

Scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.

Africa

Australia

Bacteria

Brandy

Brexit

California

Canada

Cancer

Children

Congress

DARPA

Depression

Donald Trump

Economy

Election

England

Facebook

Fire

France

Gamers

Genes

Girls

Gold

Government

Honda

Hotels

India

Ireland

Kids

London

Mexico

Money

Music

New York

Oscars

Planes

Police

President

Russia

Scientists

Sleep

SPA

Targus

Technology

Teeth

Uber

United States

Washington

White House

Women

advertising